Skip to main content

Table 5 Association of intervention (cinacalcet use) with all-cause mortality (Cox-regression analysis- univariable model)

From: A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

Variable

HR (95%CI)

p-Value

Cinacalcet

1.13 (0.39–3.2)

0.82

Age at baseline

1.07 (1.02–1.13)

0.013

Gender (Male)

2.71 (0.99–7.3)

0.05

Ethnicity (Caucasian)

2.3 (0.05–11.3)

0.47

Smoking at baseline

0.86 (0.29–2.5)

0.78

  1. HR- Hazard ratio, CI- confidence interval